Impact of Statin Therapy on Lipid Profile and Glycemic Control in Patients with Type 2 Diabetes Mellitus
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.105 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Ankit Kumar Singh und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus is strongly associated with atherogenic dyslipidemia and increased cardiovascular risk. Statins remain the cornerstone pharmacological therapy for lipid control and prevention of cardiovascular events, but their influence on glucose metabolism requires careful interpretation in diabetic patients.
Objective
To evaluate the effect of statin therapy on triglycerides, cholesterol, and blood glucose levels in patients with type 2 diabetes mellitus.
Methods
This prospective clinical study involved 70 subjects with type 2 diabetes mellitus. The principal biochemical domains assessed were triglycerides, cholesterol, and blood glucose levels in relation to statin therapy. The interpretation focused on lipid response, glycemic response, and the clinical balance between cardiovascular protection and metabolic monitoring.
Results
The study framework demonstrated the expected pharmacological benefit of statin therapy on lipid parameters, particularly cholesterol control, while also emphasizing the need for parallel glycemic surveillance. The overall interpretation is that statins provide essential cardiovascular protection in diabetes, but require monitoring of blood glucose because of their potential diabetogenic tendency.
Conclusion
The dissertation concludes that statin therapy significantly improves lipid parameters in patients with type 2 diabetes mellitus, supporting its role in cardiovascular risk reduction. However, its possible effect on glycemic control highlights the need for regular monitoring and individualized treatment.
Zitieren
APA
Singh, A. K., Kath, R. K., Tripathi, N., & Singh, V. (2026). Impact of Statin Therapy on Lipid Profile and Glycemic Control in Patients with Type 2 Diabetes Mellitus. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.105
Vancouver
Singh AK, Kath RK, Tripathi N, Singh V. Impact of Statin Therapy on Lipid Profile and Glycemic Control in Patients with Type 2 Diabetes Mellitus. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.105
BibTeX
@article{Singh2026,
author = {Singh, Ankit Kumar and Kath, R. K. and Tripathi, Neeraj and Singh, Vinay},
title = {Impact of Statin Therapy on Lipid Profile and Glycemic Control in Patients with Type 2 Diabetes Mellitus},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.105}
}
EUVIMED